Arlington Partners LLC Pfizer Inc Transaction History

Arlington Partners LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $267,085 - $312,195	-8,323 Reduced 82.54%	1,760 $58,000
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $116,595 - $134,898	-3,228 Reduced 24.25%	10,083 $369,000
Q1 2023 Apr 26, 2023	BUY	$39.39 - $51.28 $190,056 - $247,426	4,825 Added 56.86%	13,311 $543,000
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $37,449 - $48,886	-897 Reduced 9.56%	8,486 $435,000
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $5,426 - $6,624	-124 Reduced 1.3%	9,383 $411,000
Q1 2022 Apr 14, 2022	BUY	$45.75 - $56.69 $5,673 - $7,029	124 Added 1.32%	9,507 $492,000
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $48,344 - $71,662	1,170 Added 14.25%	9,383 $554,000
Q3 2021 Oct 15, 2021	BUY	$39.25 - $50.42 $322,360 - $414,099	8,213 New	8,213 $353,000
Q1 2020 Apr 13, 2020	SELL	$27.03 - $38.62 $36,247 - $51,789	-1,341 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$32.49 - $42.13 $25,992 - $33,704	-800 Reduced 37.37%	1,341 $48,000
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $7,506 - $8,428	-203 Reduced 8.66%	2,141 $93,000
Q1 2019 Apr 05, 2019	BUY	$37.5 - $41.2 $7,612 - $8,363	203 Added 9.48%	2,344 $100,000
Q4 2018 Jan 10, 2019	BUY	$38.47 - $43.86 $32,353 - $36,886	841 Added 64.69%	2,141 $93,000
Q3 2018 Oct 23, 2018	BUY	$34.47 - $41.81 $10,341 - $12,543	300 Added 30.0%	1,300 $57,000
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $31,910 - $37,020	1,000 New	1,000 $35,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.